Clinical diagnostic criteria for dementia associated with parkinson's disease
Identifieur interne : 000705 ( PascalFrancis/Corpus ); précédent : 000704; suivant : 000706Clinical diagnostic criteria for dementia associated with parkinson's disease
Auteurs : Murat Emre ; Dag Aarsland ; Richard Brown ; David J. Burn ; Charles Duyckaerts ; Yoshikino Mizuno ; Gerald Anthony Broe ; Jeffrey Cummings ; Dennis W. Dickson ; Serge Gauthier ; Jennifer Goldman ; Christopher Goetz ; Amos Korczyn ; Andrew Lees ; Richard Levy ; Irene Litvan ; Ian Mckeith ; Warren Olanow ; Werner Poewe ; Niall Quinn ; Christina Sampaio ; Eduardo Tolosa ; Bruno DuboisSource :
- Movement disorders [ 0885-3185 ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD-D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD-D. The Task Force members were assigned to sub-committees and performed a systematic review of the literature, based on pre-defined selection criteria, in order to identify the epidemiological, clinical, auxiliary, and pathological features of PD-D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point-prevelance is close to 30%, older age and akinetic-rigid form are associated with higher risk. PD-D is characterized by impairment in attention, memory, executive and visuo-spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body-type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD-D are proposed.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 07-0491115 INIST |
|---|---|
| ET : | Clinical diagnostic criteria for dementia associated with parkinson's disease |
| AU : | EMRE (Murat); AARSLAND (Dag); BROWN (Richard); BURN (David J.); DUYCKAERTS (Charles); MIZUNO (Yoshikino); BROE (Gerald Anthony); CUMMINGS (Jeffrey); DICKSON (Dennis W.); GAUTHIER (Serge); GOLDMAN (Jennifer); GOETZ (Christopher); KORCZYN (Amos); LEES (Andrew); LEVY (Richard); LITVAN (Irene); MCKEITH (Ian); OLANOW (Warren); POEWE (Werner); QUINN (Niall); SAMPAIO (Christina); TOLOSA (Eduardo); DUBOIS (Bruno) |
| AF : | Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University/Istanbul/Turquie (1 aut.); Norwegian Centre for Movement Disorders, Stavanger University Hospital/Stavanger/Norvège (2 aut.); School of Medicine, University of Bergen/Norvège (2 aut.); King's College, MRC Centre for Neurodegeneration Research, Institute of Psychiatry/London/Royaume-Uni (3 aut.); Institute for Ageing and Health, Newcastle University, Wolfson Research Centre/Newcastle upon Tyne/Royaume-Uni (4 aut.); Neuropathology Laboratory, La Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679/Paris/France (5 aut.); Department of Neurology, Juntendo University School of Medicine/Bunkyo-ku, Tokyo/Japon (6 aut.); Research Institute for Diseases of Old Ages, Juntendo University School of Medicine/Bunkyo-ku, Tokyo/Japon (6 aut.); Ageing Research Centre, Prince of Wales Hospital/Randwick, New South Wales/Australie (7 aut.); Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales/Randwick, New South Wales/Australie (7 aut.); Department of Neurology, David Geffen School of Medicine at UCLA/Los Angeles, California/Etats-Unis (8 aut.); Department of Neuroscience, Mayo Clinic College of Medicine/Jacksonville, Florida/Etats-Unis (9 aut.); Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging/Montreal, Quebec/Canada (10 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis (11 aut., 12 aut.); Department of Neurology, Tel-Aviv University/Ramat -Aviv/Israël (13 aut.); Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square/London/Royaume-Uni (14 aut.); Federation de Neurologic, INSERM U.610, AP-HP, Groupe Hospitalier Pitié-Salpetriere/Paris/France (15 aut.); Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine/Louisville, Kentucky/Etats-Unis (16 aut.); Wolfson Research Centre, Newcastle General Hospital/Newcastle upon Tyne/Royaume-Uni (17 aut.); Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine/New York/Etats-Unis (18 aut.); Department of Neurology, Medical University of Innsbruck/Innsbruck/Autriche (19 aut.); Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square/London/Royaume-Uni (20 aut.); Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Institute de Medicina Molecular/Lisboa/Portugal (21 aut.); Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona/Espagne (22 aut.); INSERM U610, Pavilion Claude Bernard, Hopital de la Salpetriere/Paris/France (23 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 12; Pp. 1689-1707; Bibl. 179 ref. |
| LA : | Anglais |
| EA : | Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD-D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD-D. The Task Force members were assigned to sub-committees and performed a systematic review of the literature, based on pre-defined selection criteria, in order to identify the epidemiological, clinical, auxiliary, and pathological features of PD-D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point-prevelance is close to 30%, older age and akinetic-rigid form are associated with higher risk. PD-D is characterized by impairment in attention, memory, executive and visuo-spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body-type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD-D are proposed. |
| CC : | 002B17; 002B17G; 002B17A03 |
| FD : | Système nerveux pathologie; Démence; Parkinson maladie; Diagnostic |
| FG : | Maladie dégénérative; Encéphale pathologie; Extrapyramidal syndrome; Système nerveux central pathologie |
| ED : | Nervous system diseases; Dementia; Parkinson disease; Diagnosis |
| EG : | Degenerative disease; Cerebral disorder; Extrapyramidal syndrome; Central nervous system disease |
| SD : | Sistema nervioso patología; Demencia; Parkinson enfermedad; Diagnóstico |
| LO : | INIST-20953.354000143464810020 |
| ID : | 07-0491115 |
Links to Exploration step
Pascal:07-0491115Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Clinical diagnostic criteria for dementia associated with parkinson's disease</title><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name><affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University</s1><s2>Istanbul</s2><s3>TUR</s3><sZ>1 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation><inist:fA14 i1="02"><s1>Norwegian Centre for Movement Disorders, Stavanger University Hospital</s1><s2>Stavanger</s2><s3>NOR</s3><sZ>2 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>School of Medicine, University of Bergen</s1><s3>NOR</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Brown, Richard" sort="Brown, Richard" uniqKey="Brown R" first="Richard" last="Brown">Richard Brown</name><affiliation><inist:fA14 i1="04"><s1>King's College, MRC Centre for Neurodegeneration Research, Institute of Psychiatry</s1><s2>London</s2><s3>GBR</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name><affiliation><inist:fA14 i1="05"><s1>Institute for Ageing and Health, Newcastle University, Wolfson Research Centre</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name><affiliation><inist:fA14 i1="06"><s1>Neuropathology Laboratory, La Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679</s1><s2>Paris</s2><s3>FRA</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mizuno, Yoshikino" sort="Mizuno, Yoshikino" uniqKey="Mizuno Y" first="Yoshikino" last="Mizuno">Yoshikino Mizuno</name><affiliation><inist:fA14 i1="07"><s1>Department of Neurology, Juntendo University School of Medicine</s1><s2>Bunkyo-ku, Tokyo</s2><s3>JPN</s3><sZ>6 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="08"><s1>Research Institute for Diseases of Old Ages, Juntendo University School of Medicine</s1><s2>Bunkyo-ku, Tokyo</s2><s3>JPN</s3><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Broe, Gerald Anthony" sort="Broe, Gerald Anthony" uniqKey="Broe G" first="Gerald Anthony" last="Broe">Gerald Anthony Broe</name><affiliation><inist:fA14 i1="09"><s1>Ageing Research Centre, Prince of Wales Hospital</s1><s2>Randwick, New South Wales</s2><s3>AUS</s3><sZ>7 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="10"><s1>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales</s1><s2>Randwick, New South Wales</s2><s3>AUS</s3><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Cummings, Jeffrey" sort="Cummings, Jeffrey" uniqKey="Cummings J" first="Jeffrey" last="Cummings">Jeffrey Cummings</name><affiliation><inist:fA14 i1="11"><s1>Department of Neurology, David Geffen School of Medicine at UCLA</s1><s2>Los Angeles, California</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Dickson, Dennis W" sort="Dickson, Dennis W" uniqKey="Dickson D" first="Dennis W." last="Dickson">Dennis W. Dickson</name><affiliation><inist:fA14 i1="12"><s1>Department of Neuroscience, Mayo Clinic College of Medicine</s1><s2>Jacksonville, Florida</s2><s3>USA</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name><affiliation><inist:fA14 i1="13"><s1>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging</s1><s2>Montreal, Quebec</s2><s3>CAN</s3><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Goldman, Jennifer" sort="Goldman, Jennifer" uniqKey="Goldman J" first="Jennifer" last="Goldman">Jennifer Goldman</name><affiliation><inist:fA14 i1="14"><s1>Department of Neurological Sciences, Rush University Medical Center</s1><s2>Chicago, Illinois</s2><s3>USA</s3><sZ>11 aut.</sZ><sZ>12 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name><affiliation><inist:fA14 i1="14"><s1>Department of Neurological Sciences, Rush University Medical Center</s1><s2>Chicago, Illinois</s2><s3>USA</s3><sZ>11 aut.</sZ><sZ>12 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Korczyn, Amos" sort="Korczyn, Amos" uniqKey="Korczyn A" first="Amos" last="Korczyn">Amos Korczyn</name><affiliation><inist:fA14 i1="15"><s1>Department of Neurology, Tel-Aviv University</s1><s2>Ramat -Aviv</s2><s3>ISR</s3><sZ>13 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name><affiliation><inist:fA14 i1="16"><s1>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>14 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Levy">Richard Levy</name><affiliation><inist:fA14 i1="17"><s1>Federation de Neurologic, INSERM U.610, AP-HP, Groupe Hospitalier Pitié-Salpetriere</s1><s2>Paris</s2><s3>FRA</s3><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name><affiliation><inist:fA14 i1="18"><s1>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine</s1><s2>Louisville, Kentucky</s2><s3>USA</s3><sZ>16 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mckeith, Ian" sort="Mckeith, Ian" uniqKey="Mckeith I" first="Ian" last="Mckeith">Ian Mckeith</name><affiliation><inist:fA14 i1="19"><s1>Wolfson Research Centre, Newcastle General Hospital</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>17 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Olanow, Warren" sort="Olanow, Warren" uniqKey="Olanow W" first="Warren" last="Olanow">Warren Olanow</name><affiliation><inist:fA14 i1="20"><s1>Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine</s1><s2>New York</s2><s3>USA</s3><sZ>18 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><inist:fA14 i1="21"><s1>Department of Neurology, Medical University of Innsbruck</s1><s2>Innsbruck</s2><s3>AUT</s3><sZ>19 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name><affiliation><inist:fA14 i1="22"><s1>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>20 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Sampaio, Christina" sort="Sampaio, Christina" uniqKey="Sampaio C" first="Christina" last="Sampaio">Christina Sampaio</name><affiliation><inist:fA14 i1="23"><s1>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Institute de Medicina Molecular</s1><s2>Lisboa</s2><s3>PRT</s3><sZ>21 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name><affiliation><inist:fA14 i1="24"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona</s1><s3>ESP</s3><sZ>22 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name><affiliation><inist:fA14 i1="25"><s1>INSERM U610, Pavilion Claude Bernard, Hopital de la Salpetriere</s1><s2>Paris</s2><s3>FRA</s3><sZ>23 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">07-0491115</idno><date when="2007">2007</date><idno type="stanalyst">PASCAL 07-0491115 INIST</idno><idno type="RBID">Pascal:07-0491115</idno><idno type="wicri:Area/PascalFrancis/Corpus">000705</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Clinical diagnostic criteria for dementia associated with parkinson's disease</title><author><name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name><affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University</s1><s2>Istanbul</s2><s3>TUR</s3><sZ>1 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name><affiliation><inist:fA14 i1="02"><s1>Norwegian Centre for Movement Disorders, Stavanger University Hospital</s1><s2>Stavanger</s2><s3>NOR</s3><sZ>2 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>School of Medicine, University of Bergen</s1><s3>NOR</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Brown, Richard" sort="Brown, Richard" uniqKey="Brown R" first="Richard" last="Brown">Richard Brown</name><affiliation><inist:fA14 i1="04"><s1>King's College, MRC Centre for Neurodegeneration Research, Institute of Psychiatry</s1><s2>London</s2><s3>GBR</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name><affiliation><inist:fA14 i1="05"><s1>Institute for Ageing and Health, Newcastle University, Wolfson Research Centre</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name><affiliation><inist:fA14 i1="06"><s1>Neuropathology Laboratory, La Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679</s1><s2>Paris</s2><s3>FRA</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mizuno, Yoshikino" sort="Mizuno, Yoshikino" uniqKey="Mizuno Y" first="Yoshikino" last="Mizuno">Yoshikino Mizuno</name><affiliation><inist:fA14 i1="07"><s1>Department of Neurology, Juntendo University School of Medicine</s1><s2>Bunkyo-ku, Tokyo</s2><s3>JPN</s3><sZ>6 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="08"><s1>Research Institute for Diseases of Old Ages, Juntendo University School of Medicine</s1><s2>Bunkyo-ku, Tokyo</s2><s3>JPN</s3><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Broe, Gerald Anthony" sort="Broe, Gerald Anthony" uniqKey="Broe G" first="Gerald Anthony" last="Broe">Gerald Anthony Broe</name><affiliation><inist:fA14 i1="09"><s1>Ageing Research Centre, Prince of Wales Hospital</s1><s2>Randwick, New South Wales</s2><s3>AUS</s3><sZ>7 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="10"><s1>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales</s1><s2>Randwick, New South Wales</s2><s3>AUS</s3><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Cummings, Jeffrey" sort="Cummings, Jeffrey" uniqKey="Cummings J" first="Jeffrey" last="Cummings">Jeffrey Cummings</name><affiliation><inist:fA14 i1="11"><s1>Department of Neurology, David Geffen School of Medicine at UCLA</s1><s2>Los Angeles, California</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Dickson, Dennis W" sort="Dickson, Dennis W" uniqKey="Dickson D" first="Dennis W." last="Dickson">Dennis W. Dickson</name><affiliation><inist:fA14 i1="12"><s1>Department of Neuroscience, Mayo Clinic College of Medicine</s1><s2>Jacksonville, Florida</s2><s3>USA</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name><affiliation><inist:fA14 i1="13"><s1>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging</s1><s2>Montreal, Quebec</s2><s3>CAN</s3><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Goldman, Jennifer" sort="Goldman, Jennifer" uniqKey="Goldman J" first="Jennifer" last="Goldman">Jennifer Goldman</name><affiliation><inist:fA14 i1="14"><s1>Department of Neurological Sciences, Rush University Medical Center</s1><s2>Chicago, Illinois</s2><s3>USA</s3><sZ>11 aut.</sZ><sZ>12 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name><affiliation><inist:fA14 i1="14"><s1>Department of Neurological Sciences, Rush University Medical Center</s1><s2>Chicago, Illinois</s2><s3>USA</s3><sZ>11 aut.</sZ><sZ>12 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Korczyn, Amos" sort="Korczyn, Amos" uniqKey="Korczyn A" first="Amos" last="Korczyn">Amos Korczyn</name><affiliation><inist:fA14 i1="15"><s1>Department of Neurology, Tel-Aviv University</s1><s2>Ramat -Aviv</s2><s3>ISR</s3><sZ>13 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name><affiliation><inist:fA14 i1="16"><s1>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>14 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Levy">Richard Levy</name><affiliation><inist:fA14 i1="17"><s1>Federation de Neurologic, INSERM U.610, AP-HP, Groupe Hospitalier Pitié-Salpetriere</s1><s2>Paris</s2><s3>FRA</s3><sZ>15 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name><affiliation><inist:fA14 i1="18"><s1>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine</s1><s2>Louisville, Kentucky</s2><s3>USA</s3><sZ>16 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mckeith, Ian" sort="Mckeith, Ian" uniqKey="Mckeith I" first="Ian" last="Mckeith">Ian Mckeith</name><affiliation><inist:fA14 i1="19"><s1>Wolfson Research Centre, Newcastle General Hospital</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>17 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Olanow, Warren" sort="Olanow, Warren" uniqKey="Olanow W" first="Warren" last="Olanow">Warren Olanow</name><affiliation><inist:fA14 i1="20"><s1>Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine</s1><s2>New York</s2><s3>USA</s3><sZ>18 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><inist:fA14 i1="21"><s1>Department of Neurology, Medical University of Innsbruck</s1><s2>Innsbruck</s2><s3>AUT</s3><sZ>19 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name><affiliation><inist:fA14 i1="22"><s1>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>20 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Sampaio, Christina" sort="Sampaio, Christina" uniqKey="Sampaio C" first="Christina" last="Sampaio">Christina Sampaio</name><affiliation><inist:fA14 i1="23"><s1>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Institute de Medicina Molecular</s1><s2>Lisboa</s2><s3>PRT</s3><sZ>21 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name><affiliation><inist:fA14 i1="24"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona</s1><s3>ESP</s3><sZ>22 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name><affiliation><inist:fA14 i1="25"><s1>INSERM U610, Pavilion Claude Bernard, Hopital de la Salpetriere</s1><s2>Paris</s2><s3>FRA</s3><sZ>23 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dementia</term><term>Diagnosis</term><term>Nervous system diseases</term><term>Parkinson disease</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term><term>Démence</term><term>Parkinson maladie</term><term>Diagnostic</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD-D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD-D. The Task Force members were assigned to sub-committees and performed a systematic review of the literature, based on pre-defined selection criteria, in order to identify the epidemiological, clinical, auxiliary, and pathological features of PD-D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point-prevelance is close to 30%, older age and akinetic-rigid form are associated with higher risk. PD-D is characterized by impairment in attention, memory, executive and visuo-spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body-type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD-D are proposed.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>22</s2></fA05><fA06><s2>12</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Clinical diagnostic criteria for dementia associated with parkinson's disease</s1></fA08><fA11 i1="01" i2="1"><s1>EMRE (Murat)</s1></fA11><fA11 i1="02" i2="1"><s1>AARSLAND (Dag)</s1></fA11><fA11 i1="03" i2="1"><s1>BROWN (Richard)</s1></fA11><fA11 i1="04" i2="1"><s1>BURN (David J.)</s1></fA11><fA11 i1="05" i2="1"><s1>DUYCKAERTS (Charles)</s1></fA11><fA11 i1="06" i2="1"><s1>MIZUNO (Yoshikino)</s1></fA11><fA11 i1="07" i2="1"><s1>BROE (Gerald Anthony)</s1></fA11><fA11 i1="08" i2="1"><s1>CUMMINGS (Jeffrey)</s1></fA11><fA11 i1="09" i2="1"><s1>DICKSON (Dennis W.)</s1></fA11><fA11 i1="10" i2="1"><s1>GAUTHIER (Serge)</s1></fA11><fA11 i1="11" i2="1"><s1>GOLDMAN (Jennifer)</s1></fA11><fA11 i1="12" i2="1"><s1>GOETZ (Christopher)</s1></fA11><fA11 i1="13" i2="1"><s1>KORCZYN (Amos)</s1></fA11><fA11 i1="14" i2="1"><s1>LEES (Andrew)</s1></fA11><fA11 i1="15" i2="1"><s1>LEVY (Richard)</s1></fA11><fA11 i1="16" i2="1"><s1>LITVAN (Irene)</s1></fA11><fA11 i1="17" i2="1"><s1>MCKEITH (Ian)</s1></fA11><fA11 i1="18" i2="1"><s1>OLANOW (Warren)</s1></fA11><fA11 i1="19" i2="1"><s1>POEWE (Werner)</s1></fA11><fA11 i1="20" i2="1"><s1>QUINN (Niall)</s1></fA11><fA11 i1="21" i2="1"><s1>SAMPAIO (Christina)</s1></fA11><fA11 i1="22" i2="1"><s1>TOLOSA (Eduardo)</s1></fA11><fA11 i1="23" i2="1"><s1>DUBOIS (Bruno)</s1></fA11><fA14 i1="01"><s1>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University</s1><s2>Istanbul</s2><s3>TUR</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Norwegian Centre for Movement Disorders, Stavanger University Hospital</s1><s2>Stavanger</s2><s3>NOR</s3><sZ>2 aut.</sZ></fA14><fA14 i1="03"><s1>School of Medicine, University of Bergen</s1><s3>NOR</s3><sZ>2 aut.</sZ></fA14><fA14 i1="04"><s1>King's College, MRC Centre for Neurodegeneration Research, Institute of Psychiatry</s1><s2>London</s2><s3>GBR</s3><sZ>3 aut.</sZ></fA14><fA14 i1="05"><s1>Institute for Ageing and Health, Newcastle University, Wolfson Research Centre</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>4 aut.</sZ></fA14><fA14 i1="06"><s1>Neuropathology Laboratory, La Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679</s1><s2>Paris</s2><s3>FRA</s3><sZ>5 aut.</sZ></fA14><fA14 i1="07"><s1>Department of Neurology, Juntendo University School of Medicine</s1><s2>Bunkyo-ku, Tokyo</s2><s3>JPN</s3><sZ>6 aut.</sZ></fA14><fA14 i1="08"><s1>Research Institute for Diseases of Old Ages, Juntendo University School of Medicine</s1><s2>Bunkyo-ku, Tokyo</s2><s3>JPN</s3><sZ>6 aut.</sZ></fA14><fA14 i1="09"><s1>Ageing Research Centre, Prince of Wales Hospital</s1><s2>Randwick, New South Wales</s2><s3>AUS</s3><sZ>7 aut.</sZ></fA14><fA14 i1="10"><s1>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales</s1><s2>Randwick, New South Wales</s2><s3>AUS</s3><sZ>7 aut.</sZ></fA14><fA14 i1="11"><s1>Department of Neurology, David Geffen School of Medicine at UCLA</s1><s2>Los Angeles, California</s2><s3>USA</s3><sZ>8 aut.</sZ></fA14><fA14 i1="12"><s1>Department of Neuroscience, Mayo Clinic College of Medicine</s1><s2>Jacksonville, Florida</s2><s3>USA</s3><sZ>9 aut.</sZ></fA14><fA14 i1="13"><s1>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging</s1><s2>Montreal, Quebec</s2><s3>CAN</s3><sZ>10 aut.</sZ></fA14><fA14 i1="14"><s1>Department of Neurological Sciences, Rush University Medical Center</s1><s2>Chicago, Illinois</s2><s3>USA</s3><sZ>11 aut.</sZ><sZ>12 aut.</sZ></fA14><fA14 i1="15"><s1>Department of Neurology, Tel-Aviv University</s1><s2>Ramat -Aviv</s2><s3>ISR</s3><sZ>13 aut.</sZ></fA14><fA14 i1="16"><s1>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>14 aut.</sZ></fA14><fA14 i1="17"><s1>Federation de Neurologic, INSERM U.610, AP-HP, Groupe Hospitalier Pitié-Salpetriere</s1><s2>Paris</s2><s3>FRA</s3><sZ>15 aut.</sZ></fA14><fA14 i1="18"><s1>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine</s1><s2>Louisville, Kentucky</s2><s3>USA</s3><sZ>16 aut.</sZ></fA14><fA14 i1="19"><s1>Wolfson Research Centre, Newcastle General Hospital</s1><s2>Newcastle upon Tyne</s2><s3>GBR</s3><sZ>17 aut.</sZ></fA14><fA14 i1="20"><s1>Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine</s1><s2>New York</s2><s3>USA</s3><sZ>18 aut.</sZ></fA14><fA14 i1="21"><s1>Department of Neurology, Medical University of Innsbruck</s1><s2>Innsbruck</s2><s3>AUT</s3><sZ>19 aut.</sZ></fA14><fA14 i1="22"><s1>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square</s1><s2>London</s2><s3>GBR</s3><sZ>20 aut.</sZ></fA14><fA14 i1="23"><s1>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Institute de Medicina Molecular</s1><s2>Lisboa</s2><s3>PRT</s3><sZ>21 aut.</sZ></fA14><fA14 i1="24"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona</s1><s3>ESP</s3><sZ>22 aut.</sZ></fA14><fA14 i1="25"><s1>INSERM U610, Pavilion Claude Bernard, Hopital de la Salpetriere</s1><s2>Paris</s2><s3>FRA</s3><sZ>23 aut.</sZ></fA14><fA20><s1>1689-1707</s1></fA20><fA21><s1>2007</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000143464810020</s5></fA43><fA44><s0>0000</s0><s1>© 2007 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>179 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>07-0491115</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD-D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD-D. The Task Force members were assigned to sub-committees and performed a systematic review of the literature, based on pre-defined selection criteria, in order to identify the epidemiological, clinical, auxiliary, and pathological features of PD-D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point-prevelance is close to 30%, older age and akinetic-rigid form are associated with higher risk. PD-D is characterized by impairment in attention, memory, executive and visuo-spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body-type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD-D are proposed.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B17G</s0></fC02><fC02 i1="03" i2="X"><s0>002B17A03</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Démence</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Dementia</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Demencia</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Diagnostic</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Diagnosis</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Diagnóstico</s0><s5>09</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Encéphale pathologie</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>40</s5></fC07><fN21><s1>323</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 07-0491115 INIST</NO><ET>Clinical diagnostic criteria for dementia associated with parkinson's disease</ET><AU>EMRE (Murat); AARSLAND (Dag); BROWN (Richard); BURN (David J.); DUYCKAERTS (Charles); MIZUNO (Yoshikino); BROE (Gerald Anthony); CUMMINGS (Jeffrey); DICKSON (Dennis W.); GAUTHIER (Serge); GOLDMAN (Jennifer); GOETZ (Christopher); KORCZYN (Amos); LEES (Andrew); LEVY (Richard); LITVAN (Irene); MCKEITH (Ian); OLANOW (Warren); POEWE (Werner); QUINN (Niall); SAMPAIO (Christina); TOLOSA (Eduardo); DUBOIS (Bruno)</AU><AF>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul Faculty of Medicine, Istanbul University/Istanbul/Turquie (1 aut.); Norwegian Centre for Movement Disorders, Stavanger University Hospital/Stavanger/Norvège (2 aut.); School of Medicine, University of Bergen/Norvège (2 aut.); King's College, MRC Centre for Neurodegeneration Research, Institute of Psychiatry/London/Royaume-Uni (3 aut.); Institute for Ageing and Health, Newcastle University, Wolfson Research Centre/Newcastle upon Tyne/Royaume-Uni (4 aut.); Neuropathology Laboratory, La Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679/Paris/France (5 aut.); Department of Neurology, Juntendo University School of Medicine/Bunkyo-ku, Tokyo/Japon (6 aut.); Research Institute for Diseases of Old Ages, Juntendo University School of Medicine/Bunkyo-ku, Tokyo/Japon (6 aut.); Ageing Research Centre, Prince of Wales Hospital/Randwick, New South Wales/Australie (7 aut.); Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales/Randwick, New South Wales/Australie (7 aut.); Department of Neurology, David Geffen School of Medicine at UCLA/Los Angeles, California/Etats-Unis (8 aut.); Department of Neuroscience, Mayo Clinic College of Medicine/Jacksonville, Florida/Etats-Unis (9 aut.); Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging/Montreal, Quebec/Canada (10 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis (11 aut., 12 aut.); Department of Neurology, Tel-Aviv University/Ramat -Aviv/Israël (13 aut.); Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square/London/Royaume-Uni (14 aut.); Federation de Neurologic, INSERM U.610, AP-HP, Groupe Hospitalier Pitié-Salpetriere/Paris/France (15 aut.); Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine/Louisville, Kentucky/Etats-Unis (16 aut.); Wolfson Research Centre, Newcastle General Hospital/Newcastle upon Tyne/Royaume-Uni (17 aut.); Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine/New York/Etats-Unis (18 aut.); Department of Neurology, Medical University of Innsbruck/Innsbruck/Autriche (19 aut.); Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square/London/Royaume-Uni (20 aut.); Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Institute de Medicina Molecular/Lisboa/Portugal (21 aut.); Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona/Espagne (22 aut.); INSERM U610, Pavilion Claude Bernard, Hopital de la Salpetriere/Paris/France (23 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 12; Pp. 1689-1707; Bibl. 179 ref.</SO><LA>Anglais</LA><EA>Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD-D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD-D. The Task Force members were assigned to sub-committees and performed a systematic review of the literature, based on pre-defined selection criteria, in order to identify the epidemiological, clinical, auxiliary, and pathological features of PD-D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point-prevelance is close to 30%, older age and akinetic-rigid form are associated with higher risk. PD-D is characterized by impairment in attention, memory, executive and visuo-spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body-type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD-D are proposed.</EA><CC>002B17; 002B17G; 002B17A03</CC><FD>Système nerveux pathologie; Démence; Parkinson maladie; Diagnostic</FD><FG>Maladie dégénérative; Encéphale pathologie; Extrapyramidal syndrome; Système nerveux central pathologie</FG><ED>Nervous system diseases; Dementia; Parkinson disease; Diagnosis</ED><EG>Degenerative disease; Cerebral disorder; Extrapyramidal syndrome; Central nervous system disease</EG><SD>Sistema nervioso patología; Demencia; Parkinson enfermedad; Diagnóstico</SD><LO>INIST-20953.354000143464810020</LO><ID>07-0491115</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000705 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000705 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:07-0491115
|texte= Clinical diagnostic criteria for dementia associated with parkinson's disease
}}
| This area was generated with Dilib version V0.6.29. |  |